ATE231399T1 - Verwendung eines kationischen polymer zur herstellung von nukleinsäure-komplexe und verwandte zusammensetzungen - Google Patents
Verwendung eines kationischen polymer zur herstellung von nukleinsäure-komplexe und verwandte zusammensetzungenInfo
- Publication number
- ATE231399T1 ATE231399T1 AT98402142T AT98402142T ATE231399T1 AT E231399 T1 ATE231399 T1 AT E231399T1 AT 98402142 T AT98402142 T AT 98402142T AT 98402142 T AT98402142 T AT 98402142T AT E231399 T1 ATE231399 T1 AT E231399T1
- Authority
- AT
- Austria
- Prior art keywords
- nucleic acid
- cationic polymer
- acid complexes
- related compositions
- producing nucleic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98402142A EP0987029B1 (de) | 1998-08-28 | 1998-08-28 | Verwendung eines kationischen Polymer zur Herstellung von Nukleinsäure-Komplexe und verwandte Zusammensetzungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE231399T1 true ATE231399T1 (de) | 2003-02-15 |
Family
ID=8235477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98402142T ATE231399T1 (de) | 1998-08-28 | 1998-08-28 | Verwendung eines kationischen polymer zur herstellung von nukleinsäure-komplexe und verwandte zusammensetzungen |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0987029B1 (de) |
| JP (1) | JP2000135082A (de) |
| AT (1) | ATE231399T1 (de) |
| AU (1) | AU750696B2 (de) |
| CA (1) | CA2281442A1 (de) |
| DE (1) | DE69810925T2 (de) |
| DK (1) | DK0987029T3 (de) |
| ES (1) | ES2191269T3 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2424967A1 (en) * | 2000-10-09 | 2003-04-04 | Bayer Aktiengesellschaft | Complexes for transferring nucleic acids into cells |
| EP1352072A4 (de) * | 2001-01-17 | 2004-09-01 | Zycos Inc | Formulierungen für die zuführung von nukleinsäuren |
| FR2928373B1 (fr) | 2008-03-05 | 2010-12-31 | Centre Nat Rech Scient | Polymere derive de la polyethylenimine lineaire pour le transfert de gene. |
| EP3235513A1 (de) * | 2016-04-18 | 2017-10-25 | Université de Liège | Verbesserungen an oder im zusammenhang mit organischem material |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE159262T1 (de) * | 1992-07-22 | 1997-11-15 | Hoechst Ag | Hydrophile zentren aufweisende polyvinylamin- derivate, verfahren zu ihrer herstellung sowie die verwendung der verbindungen als arzneimittel, wirkstoffträger und nahrungsmittelhilfsstoff |
| US5629184A (en) * | 1995-01-25 | 1997-05-13 | Amgen Inc. | Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides |
| FR2744453B1 (fr) * | 1996-02-05 | 1998-07-10 | Transgene Sa | Composes lipopolyamines, compositions pharmaceutiques en comprenant, vecteurs de transfert d'acide nucleique et procede de preparation |
-
1998
- 1998-08-28 DK DK98402142T patent/DK0987029T3/da active
- 1998-08-28 EP EP98402142A patent/EP0987029B1/de not_active Expired - Lifetime
- 1998-08-28 AT AT98402142T patent/ATE231399T1/de not_active IP Right Cessation
- 1998-08-28 DE DE69810925T patent/DE69810925T2/de not_active Expired - Fee Related
- 1998-08-28 ES ES98402142T patent/ES2191269T3/es not_active Expired - Lifetime
-
1999
- 1999-08-25 CA CA002281442A patent/CA2281442A1/en not_active Abandoned
- 1999-08-25 AU AU44727/99A patent/AU750696B2/en not_active Ceased
- 1999-08-30 JP JP11244014A patent/JP2000135082A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0987029A1 (de) | 2000-03-22 |
| AU750696B2 (en) | 2002-07-25 |
| DE69810925D1 (de) | 2003-02-27 |
| EP0987029B1 (de) | 2003-01-22 |
| AU4472799A (en) | 2000-03-16 |
| DE69810925T2 (de) | 2004-01-08 |
| CA2281442A1 (en) | 2000-02-28 |
| JP2000135082A (ja) | 2000-05-16 |
| ES2191269T3 (es) | 2003-09-01 |
| DK0987029T3 (da) | 2003-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0002543A1 (hu) | Sziloxánalapú poliamidok, ilyen poliamidokat sűrítőszerként tartalmazó alapkompozíciók és kozmetikai készítmények, valamint eljárás egyes szilikon-poliamidok előállítására | |
| DE69915351D1 (de) | Funktionalisierte polyallylamine und verfahren zur herstellung davon | |
| BR0211051A (pt) | Composição polimérica, composição de poliéster e processos | |
| DE3871190D1 (de) | Polymerisationsverfahren und polymerisationskatalysator. | |
| ATE138069T1 (de) | Schwefel enthaltende kondensierte pyrimidinderivate, ihre herstellung und verwendung | |
| ATE373040T1 (de) | Fluorpolymerzusammensetzungen | |
| DE69416306D1 (de) | Sphingoglycolipid und verwendung davon | |
| ATE71090T1 (de) | Heterocyclische verbindungen und deren herstellung und verwendung. | |
| DE60306781D1 (de) | Naturstoffe und deren derivate zur prävention und behandlung von herzkreislauf-, leber- und nierenerkrankungen und für kosmetische anwendungen | |
| ATE202702T1 (de) | Verwendung von oestrogenagonisten und - antagonisten zur herstellung eines medikaments zur behandlung von atherosklerose, unabhängig von lipidsenkung | |
| CY1105047T1 (el) | Ενωσεις πυριδοπυριμιδινονης, η μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις που τις περιεχουν | |
| DE59400332D1 (de) | Vernetzbare Siloxan-Zusammensetzungen und deren Verwendung zur Herstellung von klebrige Stoffe abweisenden Überzügen | |
| ATE432956T1 (de) | Blockcopolymere und verwendung davon | |
| DE69118760D1 (de) | Salze von Triazinderivaten mit oxygenierter Phosphorsäure und ihre Verwendung in selbstlöschenden Polymerzusammensetzungen | |
| DE3678469D1 (de) | Aminosaeure-derivate und ihre anwendung zur herstellung eines antikrampfmittels. | |
| ATE231399T1 (de) | Verwendung eines kationischen polymer zur herstellung von nukleinsäure-komplexe und verwandte zusammensetzungen | |
| DE69303425D1 (de) | Polysiloxan-Stabilisatoren mit sterisch gehinderten Phenolgruppen und Oxamidgruppen | |
| DE3863883D1 (de) | Haertungskomponente und deren verwendung. | |
| EP1167418A4 (de) | Polyoxyethylenderivate mit einer endständigen, geschützten aminogruppe und verfahren zu deren herstellung | |
| EP1443042A4 (de) | Hybrid-oniumsalz | |
| DE69923860D1 (de) | Flammhemmende harzzusammensetzungen, enthaltend phosphoramide, und herstellungsmethode | |
| KR910015537A (ko) | 신규 1-아릴술포닐-2-피페리디논 유도체, 이의 제조방법, 제조용 중간체, 의약품으로서의 용도 및 이 화합물을 함유하는 조성물 | |
| DE60003671D1 (de) | Halo-derivate von 9-deoxo-9a-aza-9a-homerythromycin a | |
| DE69508370D1 (de) | Phosphonig-, phosphinig- oder phosphonsäure Derivate als Stabilisatoren für organische Materialen | |
| DE69501705D1 (de) | Verfahren zur Herstellung von optisch aktiven Piperazinderivaten und Zwischenprodukten für ihre Herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0987029 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |